Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture), By End-use (Hospitals, Laboratories, POCT), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Influenza Diagnostics Market Growth & Trends
The global influenza diagnostics market size is expected to reach USD 1.46 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 3.5% from 2022 to 2030. The increasing surveillance of the infection and the rising prevalence of chronic diseases around the world are contributing to the demand for influenza diagnostics. For instance, in September 2022, National Influenza Centres and other laboratories from 102 countries tested over 112,017 specimens between 22 August 2022 to 04 September 2022. Out of those, 3,879 tested positive for influenza viruses.
The increasing involvement of international organizations and regulations, such as WHO and the U.S. Department of Health & Human Services to control the spread of infection. The organizations are indulging in comprehensive research and development of a vaccine for influenza. It has been observed that various companies such as VIDRL, Seqirus, and CDC are developing cell culture-based vaccines. Thus, this strategic initiative is likely to have a positive impact on the market through increasing demand for cell culture technology.
For instance, in September 2022, WHO used a certified cell line including NIID-MDCK for isolating the human influenza virus. The organization also performed genetic and antigenic analysis on the cell culture-based candidate vaccine viruses. The vaccine candidates have passed two-way virus neutralization tests or hemagglutination inhibition against the cell culture prototype viruses and match the recommendation by WHO. It is anticipated that cell-culture-derived vaccine candidates will be available for development and production in 2023.
During the COVID-19 pandemic, the surveillance to monitor and detect the influenza virus drastically decreased. Similarly, the trend was witnessed in flu-related hospitalization cases between October to April. For instance, from October 2019 to April 2020, approximately 19,299 cases of hospitalization were reported in the U.S. While in the same months in 2020-21, only 232 cases were reported, hence, approximately 98% fall in the cases during the peak of COVID-19. However, WHO recommended countries be ready for the co-circulation of COVID-19 and influenza viruses. This encourages the regional regulations to integrate the surveillance program and step-up vaccination campaigns for flu.
The growing availability of point-of-care testing (POCT) in the area of rapid diagnostics of infectious diseases including flu, is expected to increase the demand for influenza diagnostics in developing countries. For instance, a study was conducted in October 2022, to assess the POCT scope for infectious diseases in European countries. As per the study, under surveillance, POCT is widely used for infectious diseases with significant incidence rates, such as HIV and flu.
Moreover, at the global level, flu activity is considerably low. As per the September 2022 report by WHO, the South African region has witnessed a significant rise in flu activity in the past few weeks, and majorly with influenza B viruses were reported. However, in regions such as Central Asia and Northern Africa, no detection of flu was reported. Decreasing incidence rates is anticipated to impact the growth of the market through low product development by companies.
Influenza Diagnostics Market Report Highlights
Influenza Diagnostics Market Growth & Trends
The global influenza diagnostics market size is expected to reach USD 1.46 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 3.5% from 2022 to 2030. The increasing surveillance of the infection and the rising prevalence of chronic diseases around the world are contributing to the demand for influenza diagnostics. For instance, in September 2022, National Influenza Centres and other laboratories from 102 countries tested over 112,017 specimens between 22 August 2022 to 04 September 2022. Out of those, 3,879 tested positive for influenza viruses.
The increasing involvement of international organizations and regulations, such as WHO and the U.S. Department of Health & Human Services to control the spread of infection. The organizations are indulging in comprehensive research and development of a vaccine for influenza. It has been observed that various companies such as VIDRL, Seqirus, and CDC are developing cell culture-based vaccines. Thus, this strategic initiative is likely to have a positive impact on the market through increasing demand for cell culture technology.
For instance, in September 2022, WHO used a certified cell line including NIID-MDCK for isolating the human influenza virus. The organization also performed genetic and antigenic analysis on the cell culture-based candidate vaccine viruses. The vaccine candidates have passed two-way virus neutralization tests or hemagglutination inhibition against the cell culture prototype viruses and match the recommendation by WHO. It is anticipated that cell-culture-derived vaccine candidates will be available for development and production in 2023.
During the COVID-19 pandemic, the surveillance to monitor and detect the influenza virus drastically decreased. Similarly, the trend was witnessed in flu-related hospitalization cases between October to April. For instance, from October 2019 to April 2020, approximately 19,299 cases of hospitalization were reported in the U.S. While in the same months in 2020-21, only 232 cases were reported, hence, approximately 98% fall in the cases during the peak of COVID-19. However, WHO recommended countries be ready for the co-circulation of COVID-19 and influenza viruses. This encourages the regional regulations to integrate the surveillance program and step-up vaccination campaigns for flu.
The growing availability of point-of-care testing (POCT) in the area of rapid diagnostics of infectious diseases including flu, is expected to increase the demand for influenza diagnostics in developing countries. For instance, a study was conducted in October 2022, to assess the POCT scope for infectious diseases in European countries. As per the study, under surveillance, POCT is widely used for infectious diseases with significant incidence rates, such as HIV and flu.
Moreover, at the global level, flu activity is considerably low. As per the September 2022 report by WHO, the South African region has witnessed a significant rise in flu activity in the past few weeks, and majorly with influenza B viruses were reported. However, in regions such as Central Asia and Northern Africa, no detection of flu was reported. Decreasing incidence rates is anticipated to impact the growth of the market through low product development by companies.
Influenza Diagnostics Market Report Highlights
- By test type, the RIDT segment held the largest share in 2021 and is expected to exhibit the fastest CAGR over the forecast period. Owing to the increasing strategic initiatives such as product development and expanding the scope of usage to public events by the companies, hence, driving the market growth
- By end-user, the hospital segment held the largest revenue share in 2021. This is attributed to the growing presence of underlying medical conditions such as asthma and other chronic health conditions, which increases the risk of flu complications
- North America has established a strong regional position in the market with 32.9% of the overall market share. Owing to the increasing accessibility of data on the influenza burden to the companies, and rising surveillance testing in the region
- A few of the key market players include Becton, Dickinson and Co; Quidel Corporation; F. Hoffmann-La Roche Ltd; Abbott; Thermo Fisher Scientific, Inc.; and Meridian Bioscience
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Country Wise Market: Base Estimates
1.2 Global Market: CAGR Calculation
1.3 Region-Based Segment Share Calculation
1.4 Research Scope & Assumptions
1.5 List of Data Sources
1.5.1 Data for primary interviews, by sources
1.5.2 Data for primary interviews, by region
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 INFLUENZA DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Rising Geriatric Population
3.2.2 Increasing Prevalence of Chronic Diseases
3.2.3 Government Initiatives to Counter Influenza
3.2.4 Technological Advancements
3.3 Market Restraint Analysis
3.3.1 Product Safety and High Development Costs
3.4 Influenza Diagnostics - SWOT Analysis, By Factor (political & legal, economic and technological)
3.5 Industry Analysis - Porter’s
3.6 Influenza Diagnostics Market: Market Position Analysis, 2021
3.7 COVID-19 Impact Analysis
CHAPTER 4 INFLUENZA DIAGNOSTICS MARKET: TEST TYPE ESTIMATES & TREND ANALYSIS
4.1 Influenza Diagnostics Market: Test Type Movement Analysis
4.2 RIDT
4.2.1 RIDT market, 2018 - 2030 (USD Million)
4.3 RT-PCR
4.3.1 RT-PCR market, 2018 - 2030 (USD Million)
4.4 Cell Culture
4.4.1 Cell Culture market, 2018 - 2030 (USD Million)
4.5 Others
4.5.1 Others market, 2018 - 2030 (USD Million)
CHAPTER 5 INFLUENZA DIAGNOSTICS MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1 Influenza Diagnostics Market: End-use Movement Analysis
5.2 Hospitals
5.2.1 Hospitals market, 2018 - 2030 (USD Million)
5.3 POCT
5.3.1 POCT market, 2018 - 2030 (USD Million)
5.4 Laboratories
5.4.1 Laboratories market, 2018 - 2030 (USD Million)
CHAPTER 6 INFLUENZA DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TEST TYPE, END-USE
6.1 Influenza Diagnostics Market Share By Region, 2021 & 2030
6.2 North America
6.2.1 North America Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.2.2 North America Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.2.3 U.S.
6.2.3.1 U.S. Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.2.3.2 U.S. Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.2.4 Canada
6.2.4.1 Canada Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.2.4.2 Canada Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.2 Europe Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.3.2 Germany Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3.4 U.K.
6.3.4.1 U.K. Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.4.2 U.K. Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3.5 France
6.3.5.1 France Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.5.2 France Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3.6 Italy
6.3.6.1 Italy Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.6.2 Italy Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3.7 Spain
6.3.7.1 Spain Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.7.2 Spain Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.4.2 Asia Pacific Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.4.3 Japan
6.4.3.1 Japan Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.4.3.2 Japan Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.4.4 China
6.4.4.1 China Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.4.4.2 China Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.4.5 India
6.4.5.1 India Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.4.5.2 India Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea Influenza Diagnostics market, by test type, 2017 - 2030 (USD Million)
6.4.6.2 South Korea Influenza Diagnostics market, by end-use, 2017 - 2030 (USD Million)
6.4.7 Australia
6.4.7.1 Australia Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.4.7.2 Australia Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.5.2 Latin America Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.5.3 Brazil
6.5.3.1 Brazil Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.5.3.2 Brazil Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexico Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.5.4.2 Mexico Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.5.5 Argentina
6.5.5.1 Argentina Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.5.5.2 Argentina Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.6 MEA
6.6.1 MEA Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.6.2 MEA Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.6.3.2 South Africa Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.6.4 Saudi Arabia
6.6.4.1 Saudi Arabia Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.6.4.2 Saudi Arabia Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.6.5 UAE
6.6.5.1 UAE Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.6.5.2 UAE Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy Framework
7.2 Company Profiles
7.2.1 Thermo Fisher Scientific, Inc
7.2.1.1 Company Overview
7.2.1.2 Financial Performance
7.2.1.3 Product Benchmarking
7.2.1.4 Strategic Initiatives
7.2.2 3M
7.2.2.1 Company Overview
7.2.2.2 Financial Performance
7.2.2.3 Product Benchmarking
7.2.2.4 Strategic Initiatives
7.2.3 Becton, Dickinson and Company (BD)
7.2.3.1 Company Overview
7.2.3.2 Financial Performance
7.2.3.3 Product Benchmarking
7.2.3.4 Strategic Initiatives
7.2.4 Abbott Laboratories, Inc.
7.2.4.1 Company Overview
7.2.4.2 Financial Performance
7.2.4.3 Product Benchmarking
7.2.4.4 Strategic Initiatives
7.2.5 Meridian Bioscience, Inc.
7.2.5.1 Company Overview
7.2.5.2 Financial Performance
7.2.5.3 Product Benchmarking
7.2.5.4 Strategic Initiatives
7.2.6 Quidel Corporation
7.2.6.1 Company Overview
7.2.6.2 Financial Performance
7.2.6.3 Product Benchmarking
7.2.6.4 Strategic Initiatives
7.2.7 F. Hoffmann-LA Roche AG
7.2.7.1 Company Overview
7.2.7.2 Financial Performance
7.2.7.3 Product Benchmarking
7.2.7.4 Strategic Initiatives
7.2.8 SA Scientific
7.2.8.1 Company Overview
7.2.8.2 Financial Performance
7.2.8.3 Product Benchmarking
7.2.8.4 Strategic Initiatives
7.2.9 Thermo Fisher Scientific, Inc.
7.2.9.1 Company Overview
7.2.9.2 Financial Performance
7.2.9.3 Product Benchmarking
7.2.9.4 Strategic Initiatives
7.2.10 Hologic, Inc.
7.2.10.1 Company Overview
7.2.10.2 Financial Performance
7.2.10.3 Product Benchmarking
7.2.10.4 Strategic Initiatives
1.1 Country Wise Market: Base Estimates
1.2 Global Market: CAGR Calculation
1.3 Region-Based Segment Share Calculation
1.4 Research Scope & Assumptions
1.5 List of Data Sources
1.5.1 Data for primary interviews, by sources
1.5.2 Data for primary interviews, by region
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 INFLUENZA DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Rising Geriatric Population
3.2.2 Increasing Prevalence of Chronic Diseases
3.2.3 Government Initiatives to Counter Influenza
3.2.4 Technological Advancements
3.3 Market Restraint Analysis
3.3.1 Product Safety and High Development Costs
3.4 Influenza Diagnostics - SWOT Analysis, By Factor (political & legal, economic and technological)
3.5 Industry Analysis - Porter’s
3.6 Influenza Diagnostics Market: Market Position Analysis, 2021
3.7 COVID-19 Impact Analysis
CHAPTER 4 INFLUENZA DIAGNOSTICS MARKET: TEST TYPE ESTIMATES & TREND ANALYSIS
4.1 Influenza Diagnostics Market: Test Type Movement Analysis
4.2 RIDT
4.2.1 RIDT market, 2018 - 2030 (USD Million)
4.3 RT-PCR
4.3.1 RT-PCR market, 2018 - 2030 (USD Million)
4.4 Cell Culture
4.4.1 Cell Culture market, 2018 - 2030 (USD Million)
4.5 Others
4.5.1 Others market, 2018 - 2030 (USD Million)
CHAPTER 5 INFLUENZA DIAGNOSTICS MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1 Influenza Diagnostics Market: End-use Movement Analysis
5.2 Hospitals
5.2.1 Hospitals market, 2018 - 2030 (USD Million)
5.3 POCT
5.3.1 POCT market, 2018 - 2030 (USD Million)
5.4 Laboratories
5.4.1 Laboratories market, 2018 - 2030 (USD Million)
CHAPTER 6 INFLUENZA DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TEST TYPE, END-USE
6.1 Influenza Diagnostics Market Share By Region, 2021 & 2030
6.2 North America
6.2.1 North America Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.2.2 North America Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.2.3 U.S.
6.2.3.1 U.S. Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.2.3.2 U.S. Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.2.4 Canada
6.2.4.1 Canada Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.2.4.2 Canada Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.2 Europe Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.3.2 Germany Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3.4 U.K.
6.3.4.1 U.K. Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.4.2 U.K. Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3.5 France
6.3.5.1 France Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.5.2 France Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3.6 Italy
6.3.6.1 Italy Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.6.2 Italy Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.3.7 Spain
6.3.7.1 Spain Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.3.7.2 Spain Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.4.2 Asia Pacific Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.4.3 Japan
6.4.3.1 Japan Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.4.3.2 Japan Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.4.4 China
6.4.4.1 China Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.4.4.2 China Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.4.5 India
6.4.5.1 India Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.4.5.2 India Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea Influenza Diagnostics market, by test type, 2017 - 2030 (USD Million)
6.4.6.2 South Korea Influenza Diagnostics market, by end-use, 2017 - 2030 (USD Million)
6.4.7 Australia
6.4.7.1 Australia Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.4.7.2 Australia Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.5.2 Latin America Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.5.3 Brazil
6.5.3.1 Brazil Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.5.3.2 Brazil Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexico Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.5.4.2 Mexico Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.5.5 Argentina
6.5.5.1 Argentina Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.5.5.2 Argentina Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.6 MEA
6.6.1 MEA Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.6.2 MEA Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.6.3.2 South Africa Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.6.4 Saudi Arabia
6.6.4.1 Saudi Arabia Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.6.4.2 Saudi Arabia Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
6.6.5 UAE
6.6.5.1 UAE Influenza Diagnostics market, by test type, 2018 - 2030 (USD Million)
6.6.5.2 UAE Influenza Diagnostics market, by end-use, 2018 - 2030 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy Framework
7.2 Company Profiles
7.2.1 Thermo Fisher Scientific, Inc
7.2.1.1 Company Overview
7.2.1.2 Financial Performance
7.2.1.3 Product Benchmarking
7.2.1.4 Strategic Initiatives
7.2.2 3M
7.2.2.1 Company Overview
7.2.2.2 Financial Performance
7.2.2.3 Product Benchmarking
7.2.2.4 Strategic Initiatives
7.2.3 Becton, Dickinson and Company (BD)
7.2.3.1 Company Overview
7.2.3.2 Financial Performance
7.2.3.3 Product Benchmarking
7.2.3.4 Strategic Initiatives
7.2.4 Abbott Laboratories, Inc.
7.2.4.1 Company Overview
7.2.4.2 Financial Performance
7.2.4.3 Product Benchmarking
7.2.4.4 Strategic Initiatives
7.2.5 Meridian Bioscience, Inc.
7.2.5.1 Company Overview
7.2.5.2 Financial Performance
7.2.5.3 Product Benchmarking
7.2.5.4 Strategic Initiatives
7.2.6 Quidel Corporation
7.2.6.1 Company Overview
7.2.6.2 Financial Performance
7.2.6.3 Product Benchmarking
7.2.6.4 Strategic Initiatives
7.2.7 F. Hoffmann-LA Roche AG
7.2.7.1 Company Overview
7.2.7.2 Financial Performance
7.2.7.3 Product Benchmarking
7.2.7.4 Strategic Initiatives
7.2.8 SA Scientific
7.2.8.1 Company Overview
7.2.8.2 Financial Performance
7.2.8.3 Product Benchmarking
7.2.8.4 Strategic Initiatives
7.2.9 Thermo Fisher Scientific, Inc.
7.2.9.1 Company Overview
7.2.9.2 Financial Performance
7.2.9.3 Product Benchmarking
7.2.9.4 Strategic Initiatives
7.2.10 Hologic, Inc.
7.2.10.1 Company Overview
7.2.10.2 Financial Performance
7.2.10.3 Product Benchmarking
7.2.10.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Influenza Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Table 4 Global Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 5 Global Influenza Diagnostics Market, by Region, 2018 - 2030 (USD Million)
Table 6 North America Influenza Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 8 North America Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 9 U.S. Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 10 U.S. Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 11 Canada Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 12 Canada Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 13 Europe Influenza Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 14 Europe Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 15 Europe Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 16 Germany Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 17 Germany Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 18 U.K. Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 19 U.K. Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 20 France Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 21 France Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 22 Italy Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 23 Italy Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 24 Spain Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 25 Spain Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 26 Asia Pacific Influenza Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 27 Asia Pacific Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 29 China Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 30 China Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 31 Japan Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 32 Japan Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 33 India Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 34 India Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 35 South Korea Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 36 South Korea Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 37 Australia Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 38 Australia Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 39 Latin America Influenza Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 40 Latin America Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 41 Latin America Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 42 Brazil Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 43 Brazil Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 44 Mexico Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 45 Mexico Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 46 Argentina Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 47 Argentina Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 48 Middle East & Africa Influenza Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 49 Middle East & Africa Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 50 Middle East & Africa Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 51 South Africa Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 52 South Africa Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 53 Saudi Arabia Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 54 Saudi Arabia Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 55 UAE Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 56 UAE Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Influenza Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Table 4 Global Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 5 Global Influenza Diagnostics Market, by Region, 2018 - 2030 (USD Million)
Table 6 North America Influenza Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 8 North America Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 9 U.S. Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 10 U.S. Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 11 Canada Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 12 Canada Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 13 Europe Influenza Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 14 Europe Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 15 Europe Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 16 Germany Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 17 Germany Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 18 U.K. Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 19 U.K. Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 20 France Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 21 France Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 22 Italy Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 23 Italy Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 24 Spain Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 25 Spain Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 26 Asia Pacific Influenza Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 27 Asia Pacific Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 29 China Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 30 China Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 31 Japan Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 32 Japan Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 33 India Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 34 India Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 35 South Korea Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 36 South Korea Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 37 Australia Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 38 Australia Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 39 Latin America Influenza Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 40 Latin America Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 41 Latin America Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 42 Brazil Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 43 Brazil Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 44 Mexico Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 45 Mexico Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 46 Argentina Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 47 Argentina Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 48 Middle East & Africa Influenza Diagnostics Market, by Country, 2018 - 2030 (USD Million)
Table 49 Middle East & Africa Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 50 Middle East & Africa Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 51 South Africa Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 52 South Africa Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 53 Saudi Arabia Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 54 Saudi Arabia Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
Table 55 UAE Influenza Diagnostics Market, by Test types, 2018 - 2030 (USD Million)
Table 56 UAE Influenza Diagnostics Market, by End-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Influenza Diagnostics, Market Segmentation
Fig. 8 Market Snapshot, 2021
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 16 Global Influenza Diagnostics: Test Type Movement Analysis
Fig. 17 Global Influenza Diagnostics Market, for RIDT, 2018 - 2030 (USD Million)
Fig. 18 Global Influenza Diagnostics Market, for RT-PCR, 2018 - 2030 (USD Million)
Fig. 19 Global Influenza Diagnostics Market, for Cell Culture, 2018 - 2030 (USD Million)
Fig. 20 Global Influenza Diagnostics Market, for Others, 2018 - 2030 (USD Million)
Fig. 21 Global Influenza Diagnostics: End-use Movement Analysis
Fig. 22 Global Influenza Diagnostics Market, for Hospitals, 2018 - 2030 (USD Million)
Fig. 23 Global Influenza Diagnostics Market, for POCT, 2018 - 2030 (USD Million)
Fig. 24 Global Influenza Diagnostics Market, for Laboratories, 2018 - 2030 (USD Million)
Fig. 25 Regional Marketplace: Key Takeaways
Fig. 26 Regional Outlook, 2021 & 2030
Fig. 27 Global Influenza Diagnostics: Region Movement Analysis
Fig. 28 North America Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 29 U.S. Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 30 Canada Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 31 Europe Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 32 Germany Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 33 U.K. Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 34 France Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 35 Italy Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 36 Spain Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 37 Asia Pacific Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 38 Japan Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 39 China Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 40 India Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 41 Australia Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 42 South Korea Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 43 Latin America Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 44 Brazil Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 45 Mexico Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 46 Argentina Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 47 Middle East and Africa Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 48 South Africa Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 49 Saudi Arabia Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 50 UAE Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Influenza Diagnostics, Market Segmentation
Fig. 8 Market Snapshot, 2021
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 16 Global Influenza Diagnostics: Test Type Movement Analysis
Fig. 17 Global Influenza Diagnostics Market, for RIDT, 2018 - 2030 (USD Million)
Fig. 18 Global Influenza Diagnostics Market, for RT-PCR, 2018 - 2030 (USD Million)
Fig. 19 Global Influenza Diagnostics Market, for Cell Culture, 2018 - 2030 (USD Million)
Fig. 20 Global Influenza Diagnostics Market, for Others, 2018 - 2030 (USD Million)
Fig. 21 Global Influenza Diagnostics: End-use Movement Analysis
Fig. 22 Global Influenza Diagnostics Market, for Hospitals, 2018 - 2030 (USD Million)
Fig. 23 Global Influenza Diagnostics Market, for POCT, 2018 - 2030 (USD Million)
Fig. 24 Global Influenza Diagnostics Market, for Laboratories, 2018 - 2030 (USD Million)
Fig. 25 Regional Marketplace: Key Takeaways
Fig. 26 Regional Outlook, 2021 & 2030
Fig. 27 Global Influenza Diagnostics: Region Movement Analysis
Fig. 28 North America Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 29 U.S. Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 30 Canada Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 31 Europe Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 32 Germany Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 33 U.K. Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 34 France Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 35 Italy Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 36 Spain Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 37 Asia Pacific Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 38 Japan Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 39 China Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 40 India Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 41 Australia Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 42 South Korea Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 43 Latin America Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 44 Brazil Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 45 Mexico Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 46 Argentina Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 47 Middle East and Africa Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 48 South Africa Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 49 Saudi Arabia Influenza Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 50 UAE Influenza Diagnostics Market, 2018 - 2030 (USD Million)
